Insider sale
INNATE PHARMA SA
$1.97M
921.90K shares
What this filing means
NOVO NORDISK A S plans to sell 921.90K shares of INNATE PHARMA SA valued at approximately $1.97M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/30/2025ACC: 0000950103-25-006700
921.90K
Shares to sell
$1.97M
Approx. market value
10.82M
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months7
Licensing Deal
Novo Nordisk A/S received the ordinary shares in connection with a licensing deal.
12/8/2020
3.34MAcquisition
Cash
10/17/2019
909KLicensing Deal
Novo Nordisk A/S received the ordinary shares in connection with a licensing deal.
1/18/2017
600KAcquisition
Cash
12/28/2016
142KAcquisition
Cash
6/23/2014
250KAcquisition
Cash
12/18/2009
881.06KAcquisition
Cash
6/11/2006
4.69MTotal acquired10.82M
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/8/2020 | Licensing Deal Novo Nordisk A/S received the ordinary shares in connection with a licensing deal. | 3.34M | — |
10/17/2019 | Acquisition Cash | 909K | — |
1/18/2017 | Licensing Deal Novo Nordisk A/S received the ordinary shares in connection with a licensing deal. | 600K | — |
12/28/2016 | Acquisition Cash | 142K | — |
6/23/2014 | Acquisition Cash | 250K | — |
12/18/2009 | Acquisition Cash | 881.06K | — |
6/11/2006 | Acquisition Cash | 4.69M | — |
| Total | 10.82M | ||
Planned & Completed Dispositions1
Euronext NasdaqPlanned
Units to sell
921.90K
Market value
$1.97M
5/30/2025
Total
Units
921.90K
Value
$1.97M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/30/2025 | 921.90K | $1.97M | Euronext Nasdaq | Planned |
| Total | 921.90K | $1.97M | ||